Abstract
Summary Aim To examine whether an enteral immune-modulating diet (IMD) enriched with whey-hydrolyzed peptide, fermented milk, and isomaltulose enhances gut associated lymphoid tissue (GALT) mass and function as compared with a standard enteral diet (STD). Methods Male ICR mice were randomized into the IMD ( n = 10) or STD ( n = 10) group. After 7 days of each feeding protocol, whole small intestines were harvested. GALT lymphocytes from Peyer's patches (PPs), intraepithelial spaces (IE) and the lamina propria (LP) were isolated, counted and subjected to phenotypic determination by flowcytometry (αβTCR+, γδTCR+, CD4+, CD8+ and B cells). In another set of mice (IMD; n = 13, STD; n = 13), immunoglobulin A (IgA) levels of small intestinal, nasal and broncho-alveolar washings were measured with ELISA. Results Total lymphocyte numbers in PPs and LP and absolute numbers of B cells in PPs, γδTCR + cells in IE and αβTCR+, γδTCR+, CD4+, and CD8+ cells in LP were significantly higher in the IMD than in the STD group. IgA levels of small intestinal washings were significantly higher in the IMD than in the STD group with no differences in respiratory tract IgA levels. Conclusion The new IMD increases GALT mass and gut IgA levels as compared with STD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.